Brooke Clarke
Public Communications Contact bij SYNAIRGEN PLC
Profiel
Brooke Clarke is currently the Senior Vice President & Head-Communications at Synairgen Plc since 2021.
Prior to this, she worked as the Global Head-Communications & Corporate Affairs at Hikma Pharmaceuticals Plc from 2016 to 2021 and as the Senior Director-Global Corporate Communications at Shire Plc from 2011 to 2016.
Ms. Clarke has a graduate degree from the University of London and an undergraduate degree from the University of Michigan.
Actieve functies van Brooke Clarke
| Bedrijven | Functie | Begin |
|---|---|---|
| SYNAIRGEN PLC | Public Communications Contact | 01-09-2021 |
Eerdere bekende functies van Brooke Clarke
| Bedrijven | Functie | Einde |
|---|---|---|
| HIKMA PHARMACEUTICALS PLC | Public Communications Contact | 01-02-2021 |
| SHIRE | Public Communications Contact | 01-09-2016 |
Opleiding van Brooke Clarke
| University of Michigan | Undergraduate Degree |
| University of London | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| SYNAIRGEN PLC | Health Technology |
| HIKMA PHARMACEUTICALS PLC | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |